In April 2026, the Danish Healthcare Quality Institute (DHQI) released its first Method and Process Guide for Health Technology Assessment (HTA). The guide outlines both the methodological framework for HTA and the overall process, covering topic selection, assessment, and the DHQI Council's recommendations to regions on the implementation of treatment methods (e.g., medical technologies and procedures).
In April 2026, the HTA body of Tuscany Regional Healthcare released six rapid HTA reports (four new assessments and two reassessments) on medical devices in the cardiovascular, neurovascular, and dermatology fields.
On April 1, 2026, the submission period for Joint Scientific Consultations (JSCs) requests under the EU Health Technology Assessment Regulation (HTAR) framework opened. JSCs offer health technology developers the opportunity to seek scientific advice on the information and evidence required for a potential future Joint Clinical Assessment. Requests related to both medical devices and medicines can be submitted until April 29, 2026.
On March 20, 2026, the Danish Healthcare Quality Institute (DHQI) opened a call for submissions of clinical issues for health technology assessment (analysis or evaluation). Proposals from healthcare stakeholders will undergo validation and prioritization, with selected topics taken forward for evaluation and the development of national recommendations.
In March 2026, the HTA body of Tuscany Regional Healthcare released four rapid HTA reports (three new assessments and one reassessment) on medical devices in the cardiovascular, peripheral vascular, interventional radiology, and orthopedics fields.
In January 2026, the HTA body of Tuscany Regional Healthcare published two rapid HTA reports (one new assessment and one reassessment) on medical devices in the cardiovascular and surgical fields.
In January 2026, Italy entered the operational phase of the 2026–2028 National Health Technology Assessment Program for Medical Devices (PNHTA-DM) following the release of approximately €13 million from the national medical device governance fund. Coordinated by the National Agency for Regional Health Services (AGENAS), the program strengthens Italy’s national HTA system that will impact market access and procurement decisions for medical technologies.
In December 2025, the HTA body of Tuscany Regional Healthcare published seven new rapid HTA reports on medical devices in cardiovascular, neurosurgery, neuromodulation, orthopedics, urology, and surgical fields.
On January 07, 2026, the submission period for Joint Scientific Consultations (JSCs) requests under the EU Health Technology Assessment Regulation (HTAR) framework opened. JSCs offer health technology developers the opportunity to seek scientific advice on the information and evidence required for a potential future Joint Clinical Assessment. Requests related to both medical devices and medicines can be submitted until February 04, 2026.
On December 17, 2025, the Ministry of Health published two draft HTA reports developed within the National HTA Program for Medical Devices and launched a public consultation. Reports concern continuous glucose monitoring and the treatment of benign prostatic hyperplasia. Comments can be submitted until January 16, 2026.
In December 2025, the National Institute for Health and Care Excellence (NICE) in England updated its manual on technology appraisal and highly specialised technologies. The scope and terminology were clarified, and further details were provided to support the production of technology appraisal and highly specialised technologies on HealthTech (that is, medical devices, diagnostics, digital technologies).
On December 9, 2025, the Department of Health and Social Care launched a consultation on the government’s proposals to give ministers limited powers to direct the National Institute for Health and Care Excellence (NICE) in setting the standard cost-effectiveness threshold. Comments can be submitted online by January 13, 2026.